BDBM50148004 3-[2,3-Dichloro-4-(5-{1-[2-((R)-2-guanidino-4-methyl-1-oxo-pentylamino)-acetyl]-piperidin-4-yl}-1-methyl-1H-pyrazol-3-yl)-phenoxymethyl]-benzoic acid::CHEMBL108123

SMILES [#6]-[#6](-[#6])-[#6]-[#6@@H](\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-1-[#6]-[#6]-[#6](-[#6]-[#6]-1)-c1cc(nn1-[#6])-c1ccc(-[#8]-[#6]-c2cccc(c2)-[#6](-[#8])=O)c(Cl)c1Cl

InChI Key InChIKey=DXXSRBULFHQCQV-XMMPIXPASA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50148004   

TargetInterleukin-2 receptor subunit alpha(Mus musculus)
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50148004(3-[2,3-Dichloro-4-(5-{1-[2-((R)-2-guanidino-4-meth...)
Affinity DataIC50:  400nMAssay Description:Concentration required to inhibit mouse interleukin-2 alpha receptor was determined by SPA assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed